Skip to main content

Table 2 Treatment

From: Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study

 

STEMI N = 4899

NSTEMI N = 5159

Women n = 1214

Men n = 3685

p-value

Women n = 1776

Men n = 3383

p-value

Pre-hospital thrombolysis, n (%)a

105 (8.6)

429 (11.7)

0.004

-

-

-

Coronary angiography, n (%)

1115 (91.9)

3591 (97.5)

<0.0001

1200 (67.6)

2925 (86.5)

<0.0001

Normal vessels, n (%)b

21 (1.9)

52 (1.5)

0.307

157 (13.2)

114 (3.9)

<0.0001

Atheromatosis, n (%)b

23 (1.9)

48 (1.3)

0.083

126 (10.6)

136 (4.7)

<0.0001

One-vessel disease, n (%)b

539 (48.4)

1630 (45.5)

0.086

396 (33.2)

1145 (39.4)

0.0002

Multiple-vessel or LMS disease, n (%)b

530 (47.6)

1853 (51.9)

0.017

512 (43.0)

1513 (52.0)

<0.0001

Missing angiogram, n (%)b

2 (0.2)

8 (0.2)

NS

8 (0.7)

17 (0.6)

NS

Primary PCI, n (%)c

808 (66.5)

2653 (72.0)

0.0003

-

-

-

All PCI, n (%)

936 (77.0)

3160 (85.7)

<0.0001

524 (29.5)

1598 (47.2)

<0.0001

CABG, n (%)

37 (3.0)

187 (5.1)

0.003

109 (6.1)

423 (12.5)

<0.0001

Door to balloon-time, minutesd

38 (29–55)

36 (29–52)

0.043

-

-

-

Symptom to balloon-time, minutesd

270 (170–495)

245 (155–456)

0.001

-

-

-

Symptom to angiography, daysd

-

-

-

2 (1–4)

2 (1–4)

<0.0001

  1. LMS Left main stem, PCI percutaneous coronary intervention, CABG Coronary artery bypass grafting
  2. (%) = percent of patients with available information, denominator may vary
  3. Pre-hospital or in local hospital
  4. among patients who underwent coronary angiography
  5. PCI ≤ 12 h from onset of symptoms, without prior thrombolysis
  6. median (25th–75th percentile)